<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03160482</url>
  </required_header>
  <id_info>
    <org_study_id>2017-1620</org_study_id>
    <nct_id>NCT03160482</nct_id>
  </id_info>
  <brief_title>Expression of Protein Convertases in Thyroid Nodules</brief_title>
  <official_title>The Expression of Protein Convertases Amongst Well Differentiated Thyroid Cancers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Robert Day</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Université de Sherbrooke</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nowadays, the investigation of thyroid nodules is limited by the fact that up to 49% of the
      fine needle aspirations (FNA) performed on them are of &quot;indeterminate cytological
      signification&quot;. Moreover, no reliable molecular marker for thyroid cancer have been developed
      up to this day. The goal of this project is to study the expression of a specific kind of
      protein convertase in benign and in malignant thyroid nodules to determine its potential as a
      clinically useful biomarker.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients that underwent total of subtotal thyroidectomy at the CIUSSS de l'Estrie-CHUS will
      be recruited and classified according to the pathological diagnosis. An immunohistochemistry
      technique, developed and calibrated for the specific protein convertase studied, will be
      undertaken. Results will be interpreted by a specialized pathologist.
    </textblock>
  </detailed_description>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date type="Actual">May 15, 2017</start_date>
  <completion_date type="Anticipated">October 15, 2017</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Expression pattern of the studied protein convertase</measure>
    <time_frame>Trough study completion, an average of 1 year after the patients have been operated.</time_frame>
    <description>Horseradish peroxidase staining with specific antibodies.</description>
  </primary_outcome>
  <number_of_groups>6</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Thyroid Nodule</condition>
  <arm_group>
    <arm_group_label>Papillary Carcinoma</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Follicular Carcinoma</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Colloid Nodule</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Hyperplastic Nodule</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Adenomatoid Nodule</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Follicular Adenoma</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Immunohistochemistry</intervention_name>
    <description>Immunohistochemistry procedure on the formalin-fixed, paraffin-embedded tissue.</description>
    <arm_group_label>Papillary Carcinoma</arm_group_label>
    <arm_group_label>Follicular Carcinoma</arm_group_label>
    <arm_group_label>Colloid Nodule</arm_group_label>
    <arm_group_label>Hyperplastic Nodule</arm_group_label>
    <arm_group_label>Adenomatoid Nodule</arm_group_label>
    <arm_group_label>Follicular Adenoma</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Formalin-fixed, paraffin-embedded thyroid tissue, kept at the CIUSSS de l'Estrie - CHUS
      Pathology archives
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients from the territory of the CIUSSS de l'Estrie - CHUS, that underwent a subtotal or
        total thyroidectomy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men of women, aged 18-100 y.-o.

          -  History of subtotal or total thyroidectomy at the &quot;Centre intégré universitaire de
             santé et de services sociaux de l'Estrie - Centre hospitalier universitaire de
             Sherbrooke&quot; (CIUSSS de l'Estrie - CHUS) between January 2010 and May 2016.

        Exclusion Criteria:

          -  Refusal to participate to the study.

          -  Unavailability of the formalin-fixed, paraffin-embedded tissues.

          -  Uncertain pathological diagnosis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert Day, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre de recherche du Centre hospitalier universitaire de Sherbrooke</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CIUSSS de l'Estrie - CHUS</name>
      <address>
        <city>Sherbrooke</city>
        <state>Quebec</state>
        <zip>J1G 2E8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2017</study_first_submitted>
  <study_first_submitted_qc>May 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 19, 2017</study_first_posted>
  <last_update_submitted>May 18, 2017</last_update_submitted>
  <last_update_submitted_qc>May 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 19, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Université de Sherbrooke</investigator_affiliation>
    <investigator_full_name>Robert Day</investigator_full_name>
    <investigator_title>PhD</investigator_title>
  </responsible_party>
  <keyword>Thyroid Neoplasm</keyword>
  <keyword>Papillary Carcinoma</keyword>
  <keyword>Follicular Carcinoma</keyword>
  <keyword>Colloid Nodule</keyword>
  <keyword>Hyperplastic Nodule</keyword>
  <keyword>Adenomatoid Nodule</keyword>
  <keyword>Follicular Adenoma</keyword>
  <keyword>Thyroid Cancer</keyword>
  <keyword>Bethesda Classification</keyword>
  <keyword>Biomarkers</keyword>
  <keyword>Protein convertase</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Thyroid Nodule</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

